Investor Overview

Investor Presentation
Financial News
Jul 9, 2019

Medicenna Therapeutics Corp. ("Medicenna" or the "Company") (TSX: MDNA; OTCQB: MDNAF), a clinical stage immuno-oncology company, announced today that it has received US$1,915,264 (approximately,...

Jun 26, 2019

Scientists at the NIH and FDA Demonstrate Impressive Synergy of MDNA55 with Interferons TORONTO and HOUSTON, June 26, 2019 /CNW/ - Medicenna Therapeutics Corp. ("Medicenna" or the "Company") (TSX:...

Stock Quote
Stock Chart
Upcoming Events
No events to display
Investor Contact
For more investor information, Please contact:
Elizabeth Williams, Chief Financial Officer
Email Alerts
* Required Fields